How did VinBrain come into existence?
After 26 years abroad, spending 13 years as the Director of Engineering and AI Innovation at Microsoft in the United States, I returned to Vietnam. my homeland, in 2019. The founding of VinBrain can be traced back to a series of coincidental events that occurred at that time, nearly five years ago.
Witnessing my mother's stroke firsthand on one back-home occasion made me acutely aware of healthcare challenges in Vietnam. Leaving my 13-year leadership at Microsoft, I answered Vietnam's billionaire, Chair of Vingroup, Pham Nhat Vuong's call to build a global tech alliance with Vietnamese talents, fueled by ‘forever the entrepreneurship spirit’. Consequently, the firm determination of 18 like-minded talents beside me, who bred the seed of VinBrain in 2019, led us on a mission to alleviate patient suffering and relieve the overburdened healthcare workforce through advanced AI technologies. We aspired to build a health tech company where the core technology was developed by Vietnamese talents, breaking away from the conventional practice of importing solutions from overseas. ‘Infuse AI and IoT to improve people's lives and productivity’ is the company's mission to streamline all its efforts and activities and enable diagnostic radiology and digital healthcare transformation to accelerate to the next level of excellence.
What are the key technological advancements that have propelled VinBrain's position as a leader in AI solutions for healthcare?
Bu hikaye BioSpectrum Asia dergisinin BioSpectrum Asia Feb 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye BioSpectrum Asia dergisinin BioSpectrum Asia Feb 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Giriş Yap
Australia invests $1.89B for health and medical research transformation
The government is investing in a once in a generation transformation of health and medical research in Australia.
NZ suggests new way to prevent rheumatic heart disease progression
A new way of delivering treatment to prevent rheumatic heart disease progression is significantly less painful than an almost 70-year-old existing treatment, a University of Otago-led study in New Zealand (NZ) has found.
WHO prequalifies Takeda's dengue vaccine
A new vaccine for dengue has received prequalification from the World Health Organization (WHO).
GIBF invests $10M in Israel's Nectin Therapeutics to advance ADCs
Guangzhou-Israel Biotechnology Fund (GIBF) has invested $10 million in Nectin Therapeutics.
HOYA Group to distribute AIassisted lesion detection device in US
Japan-based HOYA Group Company, PENTAX of America, Inc. (PENTAX Medical, a division of HOYA Group) and MAGENTIQ-EYE, an artificial intelligence (AI)-based medical device company, have announced their intention to form a partnership in the field of AI in gastroenterology and to examine further collaboration and strategic partnerships.
Saudi Arabia pledges $500M to protect children from polio
At the first-ever World Economic Forum (WEF) Special Meeting hosted in Riyadh recently, the Kingdom of Saudi Arabia has pledged $500 million over the next five years to support the work of the Global Polio Eradication Initiative (GPEI).
Scientists explore use of COVID-19 variant vaccine against other coronaviruses
An international consortium of researchers developing a vaccine against troublesome COVID-19 variants will receive additional CEPI funding to investigate whether it could also protect against other deadly coronaviruses.
How Thai Biotech is Thriving with Innovations
Thailand's biotech industry is rapidly evolving, positioning itself as a key player in the ASEAN regions and the global biotechnology landscape. With a strategic focus on research and development, supportive government policies and a burgeoning ecosystem of startups and research institutions, Thailand is emerging as a hotspot for biotech innovation in Southeast Asia.
Why multi-use real estate is in demand for life sciences companies
India's Biocon, Enzene Biosciences, and Meteoric Biopharmacueticals, Japan's Daiichi Sankyo, and Singapore's Hummingbird Bioscience, have all recently sought to lease, acquire, and set up shop in a mixed-use space in the US. And for those companies who wish to enter or expand in the US market, New Jersey is a top choice due to its existing infrastructure, cultural connections, robust talent and location.
"The dialogue surrounding pharmaceutical gowning is experiencing significant transformation in 2024 & beyond"
Finland-based Lindström, a leading global provider of workwear, cleanroom workwear, and mat services, is making significant strides in its expansion efforts, particularly in key markets such as India, China, Vietnam, and Turkey.